No Data
No Data
Edesa Biotech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 395.28% HC Wainwright & Co. $21 → $21 Reiterates Buy → Buy 02/14/2024 395.28% HC Wainwright & C
H.C. Wainwright Maintains Edesa Biotech(EDSA.US) With Buy Rating, Maintains Target Price $21
H.C. Wainwright analyst Vernon Bernardino maintains $Edesa Biotech(EDSA.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a success rate of 26.2
Express News | Edesa Biotech Shares Are Trading Higher After BARDA Selected the Company's Drug for a U.S. Funded Platform Trial in General Acute Respiratory Distress Syndrome
Express News | Edesa Biotech Inc: Barda Selects Co's Drug for U.S. Funded Platform Trial in General Ards
Edesa Biotech Shareholders Approve Board and Compensation Plans
Edesa Biotech | 10-Q: Quarterly report
No Data
买跌不追涨 : Not measured yet
TrytosaveabitOP 买跌不追涨: Nope! And don’t see how much cash yet?
买跌不追涨 TrytosaveabitOP: Yes, only tracking